A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease.
about
Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohortExpression and Transport of α-Synuclein at the Blood-Cerebrospinal Fluid Barrier and Effects of Manganese ExposureTotal α-synuclein levels in human blood cells, CSF, and saliva determined by a lipid-ELISA.α-synuclein transfer through tunneling nanotubes occurs in SH-SY5Y cells and primary brain pericytes from Parkinson's disease patientsAlpha-synuclein spreading in M83 mice brain revealed by detection of pathological α-synuclein by enhanced ELISA.Autoimmune antibody decline in Parkinson's disease and Multiple System Atrophy; a step towards immunotherapeutic strategies.Brain disposition of α-Synuclein: roles of brain barrier systems and implications for Parkinson's disease.Phosphorylated α-synuclein in Parkinson's disease: correlation depends on disease severityThe N Terminus of α-Synuclein Forms Cu(II)-Bridged Oligomers.Total and Proteinase K-Resistant α-Synuclein Levels in Erythrocytes, Determined by their Ability to Bind Phospholipids, Associate with Parkinson's Disease.Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein.A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein.Recent advances in biomarkers for Parkinson's disease focusing on biochemicals, omics and neuroimaging.Current Challenges Towards the Development of a Blood Test for Parkinson's Disease.Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?Sensitive western blotting for detection of endogenous Ser129-phosphorylated α-synuclein in intracellular and extracellular spacesNew α- and γ-synuclein immunopathological lesions in human brain.Alpha-synuclein oligomers: a new hope.α-Synuclein Interacts with Lipoproteins in Plasma.Pilot study: molecular risk factors for diagnosing sporadic Parkinson's disease based on gene expression in blood in MPTP-induced rhesus monkeys.Significant Changes in Plasma Alpha-Synuclein and Beta-Synuclein Levels in Male Children with Autism Spectrum Disorder.Diagnostic biomarkers for Parkinson's disease at a glance: where are we?Recent Advances in Biomarkers for Parkinson's Disease
P2860
Q27322563-6E05225E-29A7-4BDB-8453-A12952AD005CQ28076121-B7A43BD7-43E4-430C-AB2C-865E28FD4EE6Q28395564-3B56370D-13A4-4AE3-94F1-E9385776E45FQ30392912-01D8D7AB-B362-4AB6-BAF1-F7F5A4289DD5Q30839760-091C3EE6-A234-41AD-BDDB-94F4923EF929Q33557077-FBF04098-D00E-4C23-BDDA-F2B255AA0528Q33776552-C8248560-FA6C-4FFB-B3F2-6A5A1B19F19DQ33997655-54E1CA35-5B7C-4F4B-BF08-C85D60224725Q34460662-33202BE6-A89F-4DA2-928E-2815C08B1719Q35574641-2057E225-E62F-4FF2-A270-96BF1790AA3AQ35726772-56A17675-22F3-43B7-9EBF-9C6E9DCF4DA1Q35975840-06DACA1D-7FA7-49A1-B12D-CE1ECD2D1954Q36109452-922F7E4C-F840-4720-B6E6-026DDB40F048Q38315590-A0972293-9B32-4A7B-ABEE-A7E9C7908B26Q38725286-6C01DE64-C983-4DD4-A450-BE6F7E5E58E4Q38785080-62C340BD-2BC1-489A-BC43-77ABE75E2123Q38834595-E0850D6E-C3A3-4AB9-982D-BF966845E5DBQ42062219-F48B7A6A-3494-42ED-A85A-AF27498AAAF0Q46321755-EF4B778E-D726-416A-AA97-0D9F50BBFB1CQ47099710-4D4C832E-DACA-4EED-867D-6116BF6D9C16Q47124757-9AA0696B-D670-4216-887E-4CE3B0E7029FQ55511344-FC644392-CBBE-42AB-870B-93316F99B4B7Q57142239-A3CF2877-8BAD-482A-B110-8224919E329BQ58572579-205DFAE0-C8DE-40C2-A8DE-88955A2FB149
P2860
A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A longitudinal study on α-synu ...... arker for Parkinson's disease.
@en
A longitudinal study on α-synu ...... arker for Parkinson's disease.
@nl
type
label
A longitudinal study on α-synu ...... arker for Parkinson's disease.
@en
A longitudinal study on α-synu ...... arker for Parkinson's disease.
@nl
prefLabel
A longitudinal study on α-synu ...... arker for Parkinson's disease.
@en
A longitudinal study on α-synu ...... arker for Parkinson's disease.
@nl
P2093
P2860
P921
P356
P1433
P1476
A longitudinal study on α-synu ...... marker for Parkinson's disease
@en
P2093
Angela Parker
David M A Mann
J Douglas Mitchell
Masami Masuda-Suzukake
Masato Hasegawa
Penelope G Foulds
P2860
P2888
P356
10.1038/SREP02540
P407
P577
2013-01-01T00:00:00Z